BB Heathcare Trust PLC
|Align Technology Inc||15.90 %|
|Illumina Inc||14.52 %|
|Teladoc Health Inc||13.85 %|
|Anthem Inc||12.30 %|
|Celgene Corp||10.70 %|
|Lonza Group Ltd||7.59 %|
|Bristol-Myers Squibb Company||7.35 %|
|Intuitive Surgical Inc||6.49 %|
|Esperion Therapeutics Inc||5.80 %|
|Ionis Pharmaceuticals Inc||5.51 %|
|United States||92.41 %|
|Europe - ex Euro||7.59 %|
Paul has 18 years of experience in the healthcare sector on the sell-side and was top-rated by a number of institutional investment clients. He was one of the first research partners at Redburn, Europe’s leading independent research firm. His work there included bespoke projects on healthcare portfolio construction for several institutions. Paul was previously an analyst and corporate financier at UBS Warburg and studied biochemistry.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.